Arrowhead Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Arrowhead Pharmaceuticals patents 75 in total
| Status | Patent |
|---|---|
Application | Utility: Alpha-1 AntiTrypsin (AAT) RNAi Agents, Compositions Including AAT RNAi Agents, And Methods of Use Filling date: 8 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: ORGANIC COMPOSITIONS TO TREAT EPAS1-RELATED DISEASES Filling date: 8 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 28 May 2020 |
Grant | Utility: Compositions and methods for inhibiting gene expression of LPA Filling date: 8 Sep 2025 Issue date: 26 May 2020 |
Application | Utility: RNAi Inhibition of Alpha-ENaC Expression Filling date: 8 Sep 2025 Issue date: 21 May 2020 |
Grant | Utility: Compositions and methods for inhibiting expression of RRM2 genes Filling date: 8 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3) Filling date: 8 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: RNAi agents for inhibiting expression of alpha-ENaC and methods of use Filling date: 8 Sep 2025 Issue date: 17 Mar 2020 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 13 Feb 2020 |
Grant | Utility: Organic compositions to treat beta-ENaC-related diseases Filling date: 8 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: RNAi inhibition of alpha-ENaC expression Filling date: 8 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Organic compositions to treat EPAS1-related diseases Filling date: 8 Sep 2025 Issue date: 21 Jan 2020 |
Application | Utility: Compositions and Methods for Inhibition of Factor XII Gene Expression Filling date: 8 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: Compositions and Methods for Inhibiting Gene Expression of Factor XII Filling date: 8 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES Filling date: 8 Sep 2025 Issue date: 24 Oct 2019 |
Grant | Utility: Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use Filling date: 8 Sep 2025 Issue date: 22 Oct 2019 |
Application | Utility: RNAi Agents for Hepatitis B Virus Infection Filling date: 8 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsin Filling date: 8 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES Filling date: 8 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: Targeting Ligands Filling date: 8 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: RNAi AGENTS FOR HEPATITIS B VIRUS INFECTION Filling date: 8 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: ORGANIC COMPOSITIONS TO TREAT APOC3-RELATED DISEASES Filling date: 8 Sep 2025 Issue date: 1 Aug 2019 |
Showing 50 to 75 of 75 patents.